| Nov 15 |
PLX: Self-Sustaining Rise to Lead in Renal Rare Disease
|
| Nov 15 |
Protalix BioTherapeutics Inc (PLX) Q3 2024 Earnings Call Highlights: Revenue Surge and ...
|
| Nov 14 |
Protalix BioTherapeutics, Inc. (PLX) Q3 2024 Earnings Call Transcript
|
| Nov 14 |
Protalix: Q3 Earnings Snapshot
|
| Nov 14 |
Protalix BioTherapeutics GAAP EPS of $0.03, revenue of $17.96M
|
| Nov 14 |
Protalix BioTherapeutics Reports Third Quarter 2024 Financial and Business Results
|
| Nov 14 |
Earnings Scheduled For November 14, 2024
|
| Nov 13 |
Protalix BioTherapeutics Q3 Earnings Preview
|
| Nov 7 |
Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024
|
| Oct 31 |
Accolade And 2 Other Penny Stocks To Watch On US Exchanges
|
